Page 551 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 551

Fluid and Diuretic Therapy in Heart Failure  539



              7. Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S,  In: McCall D, Rahimtoola SH, editors. Heart failure.
                Haggstrom J, et al. Guidelines for the diagnosis and treat-  New York: Chapman & Hall; 1995. p. 316–44.
                ment of canine chronic valvular heart disease. J Vet Intern  27. Creager MA, Halperin JL, Bernard DB, et al. Acute
                Med 2009;23(6):1142–50.                              regional circulatory and renal hemodynamic effects of
              8. Auld RB, Alexander EA, Levinsky NG. Proximal tubular  converting-enzyme inhibition in patients with congestive
                function in dogs with thoracic caval constriction. J Clin  heart failure. Circulation 1981;64:483–9.
                Invest 1971;50:2150–8.                           28. Decarli C, Spouse G, Larosa JL. Serum magnesium levels
              9. Barger AC, Yates FE, Rudolph AM. Renal hemodynamics  in symptomatic atrial fibrillation and their relation to
                and sodium excretion in dogs with graded valvular dam-  rhythm control by intravenous digoxin. Am J Cardiol
                age,  and  in  congestive  failure.  Am  J  Physiol  1986;57:956–9.
                1961;200:601–8.                                  29. DeFrancesco TC, Rush JE, Rozanski EA, Hansen BD,
             10. Bernay F, Bland JM, Ha ¨ggstro ¨m J, Baduel L, Combes B,  Keene BW, Moore DT, et al. Prospective clinical evalua-
                Lopez A, et al. Efficacy of spironolactone on survival in  tion of an ELISA B-type natriuretic peptide assay in the
                dogs with naturally occurring mitral regurgitation caused  diagnosis of congestive heart failure in dogs presenting
                by myxomatous mitral valve disease. J Vet Intern Med  with cough or dyspnea. J Vet Intern Med 2007;21
                2010;24(2):331–41(also see Letter to Editor:J Vet Intern  (2):243–50.
                Med 2010; in press.                              30. Dirks JH, Cirksena WJ, Berliner RW. Micropuncture
             11. Bonagura JD, Lehmkuhl LB. Fluid therapy in heart fail-  study of the effect of various diuretics on sodium reab-
                ure. In: DiBartola SJ, editor. Fluid therapy in small animal  sorption by the proximal tubules of the dog. J Clin Invest
                practice. 1st ed Philadelphia: WB Saunders; 1992.    1966;45:1875–85.
                p. 529–53.                                       31. Dormans TP, Pickkers P, Russel FG, et al. Vascular effects
             12. Bonagura JD, Ware WA. Atrial fibrillation in the dog:  of loop diuretics. Cardiovasc Res 1996;32:988–97.
                clinical findings in 81 cases. J Am Anim Hosp Assoc  32. Dormans TP, van Meyel JJ, Gerlag PG, et al. Diuretic effi-
                1986;22:111–20.                                      cacy of high dose furosemide in severe heart failure: bolus
             13. Bourland WA, Day DK, Williams HE. The role of the kid-  injection versus continuous infusion. J Am Coll Cardiol
                ney in the early nondiuretic action of furosemide to reduce  1996;28:376–82.
                elevated left atrial pressure in the hypervolemic dog.  33. Dow SJ, Fettman MJ, Smith KR, et al. Taurine depletion
                J Pharmacol Exp Ther 1977;202:221–9.                 and cardiovascular disease in adult cats fed a potassium-
             14. Bristow MR. Mechanism of action of beta-blocking agents  depleted acidified diet. Am J Vet Res 1992;53:402–5.
                in heart failure. Am J Cardiol 1997;80:26L–40L.  34. Dumont AE, Clauss RH, Reed GE, et al. Lymph drainage
             15. Calvert CA, Rawlings CA. Canine heartworm disease.  in patients with congestive heart failure: comparison with
                In: Fox PR, editor. Canine and feline cardiology. New  findings  in  hepatic  cirrhosis.  N  Engl  J  Med
                York: Churchill Livingstone; 1988. p. 519–49.        1963;269:949–52.
             16. Cannon PJ. The kidney in heart failure. N Engl J Med  35. Dzau VJ, Hollenberg NK. Renal response to captopril in
                1977;296:26–32.                                      severe heart failure: role of furosemide in natriuresis
             17. Cataliotti A, Boerrigter G, Costello-Boerrigter LC, et al.  and  reversal  of  hyponatremia.  Ann  Intern  Med
                Brain natriuretic peptide enhances renal actions of furose-  1984;100:777–81.
                mide and suppresses furosemide-induced aldosterone  36. Dzau VJ, Swartz SL. Dissociation of the prostaglandin
                activation in experimental heart failure. Circulation  and renin-angiotensin systems during captopril therapy
                2004;109:1680–5.                                     for chronic congestive heart failure secondary to coronary
             18. Chen HH, Grantham JA, Schirger JA, et al. Subcutaneous  artery disease. Am J Cardiol 1987;60:1101–5.
                administration of brain natriuretic peptide in experimental  37. Dzau VJ, Colucci WS, Hollenberg NK, et al. Relation of
                heart failure. J Am Coll Cardiol 2000;36:1706–12.    the renin-angiotensin-aldosterone system to clinical state
             19. Clark AL, Poole-Wilson PA, Coats AJ. Exercise limitation  in congestive heart failure. Circulation 1981;63:645–51.
                in chronic heart failure: central role of the periphery. J Am  38. Dzau VJ, Packer M, Lilly LS, et al. Prostaglandins in severe
                Coll Cardiol 1996;28:1092–102.                       congestive heart failure: relation to activation of the
             20. Cobb M, Michell AR. Plasma electrolyte concentrations in  renin-angiotensin system and hyponatremia. N Engl J
                dogs receiving diuretic therapy for cardiac failure. J Small  Med 1984;310:347–52.
                Anim Pract 1992;33:526–9.                        39. Eaton GE, Cody RJ, Brinkley PF. Increase in aortic
             21. Cogan MG. Atrial natriuretic peptide. Kidney Int    impedance precedes peripheral vasoconstriction at the
                1990;37:1148–60.                                     early stage of ventricular failure in the paced canine model.
             22. Cohn JN, Levine TB. Angiotensin-converting enzyme   Circulation 1993;88:2714–21.
                inhibition in congestive heart failure: the concept. Am J  40. Edwards JN. Magnesium and congestive heart failure,
                Cardiol 1982;49:1480–3.                              In: Proceedings of the American College of Veterinary
             23. Cohn JN, Levine TB, Olivar MT, et al. Plasma norepi-  Internal Medicine; 1991. p. 679–80 New Orleans.
                nephrine as a guide to prognosis in patients with chronic  41. Fenelon G, Protter AA, Stambler BS. Examination of the
                congestive heart failure. N Engl J Med 1984;311:819–23.  in vivo cardiac electrophysiological effects of nesiritide
             24. Connolly DJ. Natriuretic peptides: the feline experience.  (human brain natriuretic peptide) in conscious dogs.
                Vet Clin North Am Small Anim Pract 2010;40           J Card Fail 2002;8:320–5.
                (4):559–70.                                      42. Feuerstein GZ, Yue TL, Cheng HY, et al. Myocardial pro-
             25. Co-operative Veterinary Enalapril (COVE) Study Group .  tection by the novel vasodilating beta-blocker, carvedilol:
                Controlled clinical evaluation of enalapril in dogs with  potential relevance of anti-oxidant activity. J Hypertens
                heart failure-results of the cooperative veterinary enalapril  Suppl 1993;11:S41–S48.
                study group. J Vet Intern Med 1995;9:243–52.     43. Fichman MP, Vorherr H, Kleeman CR, et al. Diuretic-
             26. Creager MA, Cusco JA. Treatment of congestive heart  induced  hyponatremia.  Ann   Intern   Med
                failure with angiotensin-converting enzyme inhibitors.  1971;75:853–63.
   546   547   548   549   550   551   552   553   554   555   556